Recruiting
Diffuse large B-cell lymphoma refractory+2
RecruitingInvestigationalNo placebo
Study on the Effectiveness and Safety of AZD0486 for Adults with Relapsed or Refractory Non-Hodgkin Lymphoma
InvestigationalNo placebo
- Disease:Diffuse large B-cell lymphoma refractoryDiffuse large B-cell lymphoma recurrent+1
- Substances:Human Igg4 Kappa Monoclonal Antibody Against Cd3 And Cd19
Countries:
Denmark
Denmark- Participants:18–64 years · 65+ years
- Substances:Human Igg4 Kappa Monoclonal Antibody Against Cd3 And Cd19






